Q&A: What can $250 million achieve? Chief of new cancer immunotherapy institute explains By Jocelyn KaiserApr. 15, 2016 Jeffrey Bluestone says collaboration, funding to take risks will extend therapy’s reach
Brazil president signs law legalizing renegade cancer pill By Herton EscobarApr. 14, 2016 Scientists decry decision grounded in “pseudoscience”
Scientific advisers tapped to guide Biden’s cancer moonshot By Jocelyn KaiserApr. 4, 2016 Panel of 28 scientists, patient advocates, industry leaders will develop research plan
GSK to make cancer drugs more accessible in poor countries By Jon CohenMar. 31, 2016 Retiring CEO says the new approach combines societal needs with profit motive
Cells can do the twist, but sometimes their nuclei burst By Mitchell LeslieMar. 24, 2016 Crawling through tight spaces tears the membrane around the cell nucleus
Nano-balls filled with poison wipe out metastatic cancer in mice By Robert F. ServiceMar. 14, 2016 Polymers laden with chemotherapy drugs assemble at tumor cells and slip past their defenses
Vitamin C kills tumor cells with hard-to-treat mutation By Jocelyn KaiserNov. 5, 2015 Study rejuvenates hopes that vitamin C can treat some common cancers